Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,592.53
(
-0.49%
)
US TECH 100
23,604.40
(
-0.81%
)
Dow Jones
45,931.56
(
-0.64%
)
Brent Oil
104.17
(
-2.27%
)
Bitcoin
69,908.23
(
-1.87%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 73433

Thursday, 02/19/2009 4:18:27 PM

Thursday, February 19, 2009 4:18:27 PM

Post# of 257259
Re: 4Q08 MS worldwide market share by dollar sales (not # of patients)

My calculation of MS market share ($):
copaxone: 30%
avonex: 27%
other interferons: 33%
tysabri: 10%

If you compare your 4Q08 numbers to the 2Q08 numbers in #msg-31152081, two things stand out: i) Copaxone has gained the most share during the past six months; and ii) BIIB has partially undone the precipitous decline in Avonex’s share via aggressive price increases.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now